Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 5, 2017
Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus-related hepatocellular carcinomaNaoki Yoshida, Yutaka Midorikawa, Tokio Higaki, et al.
European Radiology|September 30, 2024
MR elastography vs a combination of common non-invasive tests for estimation of severe liver fibrosis in patients with hepatobiliary tumorsYujiro Nakazawa, Masahiro Okada, Kenichiro Tago, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2011
[Case report of transarterial chemoembolization to lymph node metastasis of hepatocellular carcinoma]Tomoharu Kurokawa, Masamichi Moriguchi, Takahiro Kajiwara, et al.
World Journal of Surgery|December 21, 2012
Good candidates for a third liver resection of colorectal metastasisShintaro Yamazaki, Tadatoshi Takayama, Shunji Okada, et al.
Bioscience Trends|July 28, 2020
High platelet count as a poor prognostic factor for liver cancer patients without cirrhosisYutaka Midorikawa, Tadatoshi Takayama, Tokio Higaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 30, 2018
Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapyShunsuke Yamagishi, Yutaka Midorikawa, Hisashi Nakayama, et al.
Journal of Hepatology|October 16, 2012
Marginal survival benefit in the treatment of early hepatocellular carcinomaYutaka Midorikawa, Tadatoshi Takayama, Kazuaki Shimada, et al.
BMC Gastroenterology|August 21, 2019
Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinomaYutaka Midorikawa, Tadatoshi Takayama, Hisashi Nakayama, et al.
World Journal of Surgery|February 4, 2022
Validity of the Algorithm for Liver Resection of Hepatocellular Carcinoma in the Caudate LobeNao Yoshida, Yutaka Midorikawa, Tokio Higaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 23, 2023
[Experience of Using Immune Checkpoint Inhibitors and Chemotherapy in the Upper Gastrointestinal Tract at Our Hospital]Kaiki Murai, Megumu Watabe, Masahito Ikarashi, et al.
Pageof 8